Correlation Between Inhibrx and Portmeirion Group

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Portmeirion Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Portmeirion Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Portmeirion Group PLC, you can compare the effects of market volatilities on Inhibrx and Portmeirion Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Portmeirion Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Portmeirion Group.

Diversification Opportunities for Inhibrx and Portmeirion Group

-0.15

Correlation Coefficient

Inhibrx  Portmeirion Group

Good diversification

The 3 months correlation between Inhibrx and Portmeirion is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Portmeirion Group PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Portmeirion Group PLC and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Portmeirion Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Portmeirion Group PLC has no effect on the direction of Inhibrx i.e., Inhibrx and Portmeirion Group go up and down completely randomly.

Pair Corralation between Inhibrx and Portmeirion Group

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Portmeirion Group. In addition to that, Inhibrx is 31.07 times more volatile than Portmeirion Group PLC. It trades about -0.06 of its total potential returns per unit of risk. Portmeirion Group PLC is currently generating about 0.17 per unit of volatility. If you would invest  277.00  in Portmeirion Group PLC on October 25, 2024 and sell it today you would earn a total of  3.00  from holding Portmeirion Group PLC or generate 1.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Inhibrx  vs.  Portmeirion Group PLC

Inhibrx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Portmeirion Group PLC

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Portmeirion Group PLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable primary indicators, Portmeirion Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Inhibrx and Portmeirion Group

The main advantage of trading using opposite Inhibrx and Portmeirion Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Portmeirion Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Portmeirion Group will offset losses from the drop in Portmeirion Group's long position.

The idea behind Inhibrx and Portmeirion Group PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.